1-(4-(4-Benzamido-1H-pyrrolo[3,2-c]pyridin-1-yl)phenyl)-3-(4-((4-ethyl-piperazin-1-yl)methyl)-3-trifluoromethylphenyl)urea

ID: ALA1806911

Chembl Id: CHEMBL1806911

PubChem CID: 53361439

Max Phase: Preclinical

Molecular Formula: C35H34F3N7O2

Molecular Weight: 641.70

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(-n4ccc5c(NC(=O)c6ccccc6)nccc54)cc3)cc2C(F)(F)F)CC1

Standard InChI:  InChI=1S/C35H34F3N7O2/c1-2-43-18-20-44(21-19-43)23-25-8-9-27(22-30(25)35(36,37)38)41-34(47)40-26-10-12-28(13-11-26)45-17-15-29-31(45)14-16-39-32(29)42-33(46)24-6-4-3-5-7-24/h3-17,22H,2,18-21,23H2,1H3,(H,39,42,46)(H2,40,41,47)

Standard InChI Key:  HDLRMBIQCXLNSV-UHFFFAOYSA-N

Associated Targets(Human)

A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Malme-3M (44254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M14 (47487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HS27 (243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 641.70Molecular Weight (Monoisotopic): 641.2726AlogP: 7.08#Rotatable Bonds: 8
Polar Surface Area: 94.53Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.62CX Basic pKa: 7.89CX LogP: 6.59CX LogD: 5.98
Aromatic Rings: 5Heavy Atoms: 47QED Weighted: 0.17Np Likeness Score: -1.53

References

1. El-Gamal MI, Jung MH, Lee WS, Sim T, Yoo KH, Oh CH..  (2011)  Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.,  46  (8): [PMID:21592628] [10.1016/j.ejmech.2011.04.031]
2. Abduelkarem AR, Anbar HS, Zaraei SO, Alfar AA, Al-Zoubi OS, Abdelkarem EG, El-Gamal MI..  (2020)  Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigations.,  188  [PMID:31923860] [10.1016/j.ejmech.2019.112029]

Source